The present invention relates to novel antidiabetic, hypolipidemic,
antiobesity and hypocholesterolemic compounds, their derivatives, their
analogs, their tautomeric forms, their stereoisomers, their polymorphs,
their pharmaceutically acceptable salts, their pharmaceutically
acceptable solvates and pharmaceutically acceptable compositions
containing them. More particularly, the present invention relates to
novel alkyl carboxylic acids of the general formula (I), their
derivatives, their analogs, their tautomeric forms, their stereoisomers,
their polymorphs, their pharmaceutically acceptable salts, their
pharmaceutically acceptable solvates and pharmaceutically acceptable
compositions containing them. 1